4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-013281
Options or other derivatives
- Chief Financial Officer acquired 251,734 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2024-05-13 | Grant or award · Employee Stock Option (right to buy) | +150,602 | 150,602 | D | ||
| McCombe William D. Chief Financial Officer | 2024-05-13 | Grant or award · Restricted Stock Units | +101,132 | 101,132 | D | ||
Loading xslF345X05/form4-05152024_110545.xml…